TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling
Xun Lu,Yue Yuan,Ning Cai,Dean Rao,Min Chen,Xiaoping Chen,Bixiang Zhang,Huifang Liang,Lei Zhang
DOI: https://doi.org/10.2147/JHC.S418049
2023-08-04
Journal of Hepatocellular Carcinoma
Abstract:Xun Lu, 1– 3 Yue Yuan, 4 Ning Cai, 1– 3 Dean Rao, 1– 3 Min Chen, 4 Xiaoping Chen, 1– 3 Bixiang Zhang, 1– 3 Huifang Liang, 1– 3 Lei Zhang 3, 5 1 Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 2 Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 3 Clinical Medical Research Center of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 4 Division of Gastroenterology, Department of Internal Medicine at Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China; 5 Key Laboratory of Hepatobiliary and Pancreatic Diseases of Shanxi Province (Preparatory), Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Shanxi Medical University; Shanxi Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Taiyuan, People's Republic of China Correspondence: Lei Zhang, Key Laboratory of Hepatobiliary and Pancreatic Diseases of Shanxi Province (Preparatory), Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Shanxi Medical University; Shanxi Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Taiyuan, 030032, People's Republic of China, Email Huifang Liang, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China, Email Purpose: Tripartite motif containing 55 (TRIM55) is a member of the TRIM family and functions as an E3 ubiquitin ligase. It acts as a cancer promoter or suppressor in the malignant processes of multiple cancers. However, its proliferative function in hepatocellular carcinoma (HCC) has been poorly studied, and its underlying molecular mechanism remains unclear. In the present study, we investigated the role of TRIM55 in HCC and its mechanism of promoting HCC proliferation. Materials and Methods: Protein expression levels of TRIM55 were measured in paired HCC and normal tissue samples using immunohistochemical (IHC) staining. The correlation between TRIM55 and clinical features was evaluated by statistical analysis. At the same time, overexpression and knockdown experiments, cycloheximide (CHX) interference experiments, ubiquitination, co-immunoprecipitation and immunofluorescence staining experiments, as well as animal experiments were used to evaluate the potential mechanism that TRIM55 promotes proliferation of hepatocellular carcinoma in vitro and in vivo. Results: TRIM55 expression in HCC specimens was higher compared with the corresponding non-tumor tissues. The overall survival and disease-free survival time of patients with high TRIM55 expression were shorter than those with low expression of TRIM55. Functionally, TRIM55 promoted the proliferation of HCC cells and accelerated the growth of HCC xenografts. Mechanistically, TRIM55 interacted with thyroid receptor interacting protein 6 (TRIP6) and regulate its stability by influencing the ubiquitination process, thereby affecting the Wnt signaling pathway. Conclusion: Our results indicate that TRIM55 promotes HCC proliferation by activating Wnt signaling pathways by stabilizing TRIP6. Therefore, targeting TRIM55 may be an effective therapeutic strategy to inhibit HCC growth. Keywords: TRIM55, TRIP6, hepatocellular carcinoma, proliferation Worldwide, hepatocellular carcinoma (HCC) is the fourth leading cause of death from tumors and ranks sixth in the number of incident cases. 1,2 Based on annual projections, the World Health Organization guesses that more than one million patients will die of liver cancer by 2030. 3 As we all know, the current treatment is mainly surgery, but the prognosis is still not ideal. 2,4 Hence, molecular targeted therapy has become a strategy for the prevention and treatment of HCC. 5,6 The molecular mechanism of HCC needs further study. Tripartite motif containing 55 (TRIM55) is a Protein Coding gene. It was reported that TRIM55 is involved in muscle sarcomere assembly and functions as an E3 ubiquitin ligase. 7,8 Most of the tripartite motif-containing (TRIM) family proteins have E3 ubiquitin ligase activity. 9 More and more researches have shown that TRIM proteins negatively and positively regulate carcinogenesis. 10 Changes of TRIM protein expression -Abstract Truncated-
oncology